Live feed16:05:00·1hPRReleasevia QuantisnowRevolution Medicines’ New Drug Application for Daraxonrasib Accepted for Review by U.S. FDA for Previously Treated Metastatic Pancreatic CancerByQuantisnow·Wall Street's wire, on your screen.RVMD· Revolution Medicines Inc.Health Care
